The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Over two-thirds of the top 20 global firms reported a decline in market capitalisation. The biopharmaceutical industry showed ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

The biopharma industry is highly dynamic and competitive. Companies that succeed in it must be able to tackle various aspects, including finances, marketing, regulations, investor relations, ...

Major employers and innovators recognised at ceremony showcasing Ireland’s pharmaceutical leadership, as sector marks record ...